Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
N4 Pharma Plc |
6/02 | 0,475 GBX
0,00% |
0,00% |
Nanalysis Scientific Corp. |
6/02 | 0,160 CAD
+3,23% |
+3,23% |
Nano X Imaging Ltd |
6/02 | 2,440 USD
+7,02% |
+7,02% |
Nanobiotix |
6/02 | 17,940 EUR
-1,10% |
-1,10% |
|
Nanobiotix |
6/02 | 20,850 USD
-0,86% |
-0,86% |
NanoRepro AG |
6/02 | 1,495 EUR
+3,10% |
+3,10% |
|
NanoVibronix Inc |
6/02 | 2,920 USD
+1,74% |
+1,74% |
|
NanoViricides Inc |
6/02 | 0,880 USD
+3,53% |
+3,53% |
|
Natera Inc |
6/02 | 203,040 USD
+3,02% |
+3,02% |
|
Natural Alternatives International, Inc. |
6/02 | 3,210 USD
+3,22% |
+3,22% |
|
Navidea Biopharmaceuticals Inc |
6/02 | 0,000 USD
0,00% |
0,00% |
|
Nektar Therapeutics |
6/02 | 36,810 USD
+4,81% |
+4,81% |
|
Nemaura Medical Inc |
5/02 | 0,000 USD
0,00% |
0,00% |
|
Neogen Corp. |
6/02 | 10,800 USD
+1,98% |
+1,98% |
|
Neovacs |
6/02 | 0,003 EUR
-10,71% |
-10,71% |
|
Nephros Inc |
6/02 | 3,870 USD
-0,26% |
-0,26% |
|
NervGen Pharma Corp |
6/02 | 5,350 CAD
+1,71% |
+1,71% |
|
Neurocrine Biosciences, Inc. |
6/02 | 141,200 USD
+2,37% |
+2,37% |
|
Neuronetics Inc |
6/02 | 1,560 USD
+9,86% |
+9,86% |
|
Nextcure Inc |
6/02 | 11,100 USD
+0,09% |
+0,09% |
|
NIOX Group Plc
|
6/02 | 66,000 GBX
0,00% |
0,00% |
|
Nkarta Inc |
6/02 | 2,020 USD
+5,21% |
+5,21% |
|
Novabay Pharmaceuticals Inc |
6/02 | 0,760 USD
+1,10% |
+1,10% |
|
Novacyt |
6/02 | 0,396 EUR
-3,06% |
-3,06% |
Novartis AG |
6/02 | 119,960 CHF
+0,57% |
+0,57% |
|
Novartis AG |
6/02 | 156,420 USD
+1,60% |
+1,60% |
|
Novavax, Inc. |
6/02 | 8,250 USD
+4,83% |
+4,83% |
|
Novo Nordisk A/S |
6/02 | 39,545 EUR
+5,37% |
+5,37% |
|
Novo Nordisk A/S |
6/02 | 47,640 USD
+9,92% |
+9,92% |
|
NovoCure Ltd |
6/02 | 10,140 USD
+0,50% |
+0,50% |
|
NuCana plc |
6/02 | 2,220 USD
+6,22% |
+6,22% |
|
Nuformix plc |
6/02 | 0,230 GBX
-4,17% |
-4,17% |
|
Nurix Therapeutics Inc |
6/02 | 16,850 USD
+5,64% |
+5,64% |
|
Nutriband Inc |
6/02 | 4,350 USD
+0,12% |
+0,12% |
Nyxoah |
6/02 | 3,940 EUR
+0,25% |
+0,25% |